Mycophenolate Mofetil after Rituximab for Childhood-Onset Complicated Frequently-Relapsing or Steroid-Dependent Nephrotic SyndromeKazumoto Iijima, Takeshi Ninchoji, Tomohiko Yamamura et al.|Institutional Repositories DataBase (IRDB)|2022Cited by 57
Study protocol: multicenter double-blind, randomized, placebo-controlled trial of rituximab for the treatment of childhood-onset early-stage uncomplicated frequently relapsing or steroid-dependent nephrotic syndrome (JSKDC10 trial)China Nagano, Kazumoto Iijima, Mayumi Sako et al.|BMC Nephrology|2019Cited by 19
Rituximab in combination with cyclosporine and steroid pulse therapy for childhood-onset multidrug-resistant nephrotic syndrome: a multicenter single-arm clinical trial (JSKDC11 trial)Kandai Nozu, Kazumoto Iijima, Mayumi Sako et al.|Clinical and Experimental Nephrology|2023Cited by 6
Rituximab-induced long-term remission in childhood-onset, uncomplicated, frequently relapsing or steroid-dependent nephrotic syndrome: a randomized, placebo-controlled trial and a follow-up studyKazumoto Iijima, Yosuke Inaguma, Mayumi Sako et al.|Scientific Reports|2025Cited by 5